Awareness about children’s COVID-19 vaccine


Press release, Moderna: “Moderna announces the first participant in the Phase 2/3 study of COVID-19 vaccine candidates in the pediatric population,” “Moderna announces the Phase 2/3 study of COVID-19 vaccine candidates in adolescents The first participant.”

Clinical Trials.gov: “A study describing the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals.”

Tina Tan, MD, Specialist in Pediatric Infectious Diseases, Chicago Ann and Robert H. Lurie Children’s Hospital; Professor of Pediatrics, Feinberg School of Medicine, Northwestern University.

Sean O’Leary, MD, Professor of Pediatrics at the University of Colorado Anschutz School of Medicine; Vice Chairman of the Infectious Disease Committee of the American Academy of Pediatrics.

Dr. Yvonne Maldonado, Chairman of the Infectious Disease Committee of the American Academy of Pediatrics; Director of the Pediatric Infectious Diseases Department, Stanford University School of Medicine, Stanford, California.

American Academy of Pediatrics: “Children and COVID-19: State-level data report.”

Medrxiv.org: “SARS-CoV-2 antibodies were detected in human breast milk after vaccination”, “SARS-CoV-2 antibodies were detected in pregnant women after umbilical cord blood inoculation”.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *